{"id":"https://openalex.org/W2582044074","doi":"https://doi.org/10.1182/blood.v124.21.2136.2136","title":"Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study","display_name":"Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2582044074","doi":"https://doi.org/10.1182/blood.v124.21.2136.2136","mag":"2582044074"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.2136.2136","doi":"https://doi.org/10.1182/blood.v124.21.2136.2136","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.2136.2136","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072525377","display_name":"Berdien E. Oortgiesen","orcid":"https://orcid.org/0000-0001-8401-9144","observed_orcids":["https://orcid.org/0000-0001-8401-9144"]},"institutions":[{"id":"https://openalex.org/I2802652803","display_name":"Medisch Centrum Leeuwarden","ror":"https://ror.org/0283nw634","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802652803","https://openalex.org/I4405259012"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Berdien Oortgiesen","raw_affiliation_strings":["Medical Center Leeuwarden, Leeuwarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Center Leeuwarden, Leeuwarden, Netherlands","institution_ids":["https://openalex.org/I2802652803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010075077","display_name":"Eric Nico van Roon","orcid":"https://orcid.org/0000-0001-8629-7535","observed_orcids":["https://orcid.org/0000-0001-8629-7535"]},"institutions":[{"id":"https://openalex.org/I2802652803","display_name":"Medisch Centrum Leeuwarden","ror":"https://ror.org/0283nw634","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802652803","https://openalex.org/I4405259012"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Eric N. van Roon","raw_affiliation_strings":["Medical Center Leeuwarden, Leeuwarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Center Leeuwarden, Leeuwarden, Netherlands","institution_ids":["https://openalex.org/I2802652803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110068950","display_name":"Peter Joosten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802652803","display_name":"Medisch Centrum Leeuwarden","ror":"https://ror.org/0283nw634","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802652803","https://openalex.org/I4405259012"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Peter Joosten","raw_affiliation_strings":["Medical Center Leeuwarden, Leeuwarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Center Leeuwarden, Leeuwarden, Netherlands","institution_ids":["https://openalex.org/I2802652803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110940042","display_name":"Robby E. Kibbelaar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Robby Kibbelaar","raw_affiliation_strings":["Pathology Friesland, Leeuwarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology Friesland, Leeuwarden, Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068032469","display_name":"Huib Storm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802652803","display_name":"Medisch Centrum Leeuwarden","ror":"https://ror.org/0283nw634","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802652803","https://openalex.org/I4405259012"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Huib Storm","raw_affiliation_strings":["Medical Center Leeuwarden, Leeuwarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Center Leeuwarden, Leeuwarden, Netherlands","institution_ids":["https://openalex.org/I2802652803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011657059","display_name":"Sjoerd Hovenga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118985","display_name":"Ziekenhuis Nij Smellinghe","ror":"https://ror.org/030gj2p37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210118985"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sjoerd Hovenga","raw_affiliation_strings":["Nijsmellinghe, Drachten, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nijsmellinghe, Drachten, Netherlands","institution_ids":["https://openalex.org/I4210118985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006216219","display_name":"Bastiaan P. van Rees","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259299","display_name":"Tjongerschans","ror":"https://ror.org/021dfp132","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4405259012","https://openalex.org/I4405259299"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Bas P Van Rees","raw_affiliation_strings":["Tjongerschans Hospital, Heerenveen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tjongerschans Hospital, Heerenveen, Netherlands","institution_ids":["https://openalex.org/I4405259299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089804114","display_name":"Gerhard Woolthuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405260767","display_name":"Antonius Ziekenhuis","ror":"https://ror.org/0489xrh07","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4405260767"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Gerhard Woolthuis","raw_affiliation_strings":["Antonius Hospital, Sneek, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antonius Hospital, Sneek, Netherlands","institution_ids":["https://openalex.org/I4405260767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045583556","display_name":"Nic J.G.M. Veeger","orcid":"https://orcid.org/0000-0002-1492-7937","observed_orcids":["https://orcid.org/0000-0002-1492-7937"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Nic J.G.M. Veeger","raw_affiliation_strings":["University of Groningen, University Medical Center Groningen, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Groningen, University Medical Center Groningen, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027058055","display_name":"Mels Hoogendoorn","orcid":"https://orcid.org/0000-0001-8032-2592","observed_orcids":["https://orcid.org/0000-0001-8032-2592"]},"institutions":[{"id":"https://openalex.org/I2802652803","display_name":"Medisch Centrum Leeuwarden","ror":"https://ror.org/0283nw634","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802652803","https://openalex.org/I4405259012"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Mels Hoogendoorn","raw_affiliation_strings":["Medical Center Leeuwarden, Leeuwarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Center Leeuwarden, Leeuwarden, Netherlands","institution_ids":["https://openalex.org/I2802652803"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5006216219","https://openalex.org/A5010075077","https://openalex.org/A5027058055","https://openalex.org/A5045583556","https://openalex.org/A5068032469","https://openalex.org/A5072525377","https://openalex.org/A5089804114","https://openalex.org/A5110940042"],"corresponding_institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384","https://openalex.org/I2802652803","https://openalex.org/I4405259299","https://openalex.org/I4405260767"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2121,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.63161347,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"124","issue":"21","first_page":"2136","last_page":"2136"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.9039999842643738},{"id":"https://openalex.org/keywords/novel-agents","display_name":"novel agents","score":0.5709999799728394},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.9200000166893005},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":1.0},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":1.0},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8109999895095825},{"id":"https://openalex.org/keywords/age-as-prognostic-factor","display_name":"age as prognostic factor","score":0.5419999957084656},{"id":"https://openalex.org/keywords/hypercalcemia","display_name":"hypercalcemia","score":0.7870000004768372},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.9039999842643738},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.9470000267028809},{"id":"https://openalex.org/keywords/bone-lesions","display_name":"bone lesions","score":0.9660000205039978},{"id":"https://openalex.org/keywords/first-clinical-manifestation","display_name":"first clinical manifestation","score":0.7139999866485596},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8561756610870361},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7586976289749146},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.664810061454773},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6589503288269043},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6080527901649475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5319457650184631},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5100222229957581},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.501910924911499},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.45860207080841064},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.43018150329589844},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4249178469181061},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37871015071868896},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1182/blood.v124.21.2136.2136","doi":"https://doi.org/10.1182/blood.v124.21.2136.2136","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.2136.2136","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/111f917b-2590-4283-ba7d-03cd64b090f2","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/111f917b-2590-4283-ba7d-03cd64b090f2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Oortgiesen , B , Van Roon , E N , Joosten , P , Kibbelaar , R , Storm , H , Hovenga , S , Van Rees , B P , Woolthuis , G , Veeger , N J G M &amp; Hoogendoorn , M 2014 , ' Overall survival patterns in patients with multiple myeloma in the era of novel agents and the role of initial clinical presentation and comorbidities: A population-based study ' , Blood , vol. 124 , no. 21 , pp. 2136 . &lt; http://www.bloodjournal.org/content/124/21/2136/ &gt;","raw_type":"article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/111f917b-2590-4283-ba7d-03cd64b090f2","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/111f917b-2590-4283-ba7d-03cd64b090f2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 124(21). AMER SOC HEMATOLOGY","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2593824879","https://openalex.org/W1950265463","https://openalex.org/W2518740313","https://openalex.org/W1972960382","https://openalex.org/W2555066850","https://openalex.org/W7045362401","https://openalex.org/W2560921477","https://openalex.org/W1986914158","https://openalex.org/W4386052266","https://openalex.org/W2919815273"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Clinical":[2],"trials":[3],"have":[4,560,585],"shown":[5],"improved":[6,41,535],"response":[7,104],"rates,":[8],"progression-free":[9],"survival":[10,13,341],"and":[11,28,47,103,121,166,175,201,221,263,314,333,395,407,438,445,495,500,513,524,627,692,698],"overall":[12],"(OS)":[14],"in":[15,43,51,53,63,67,81,86,93,135,152,156,160,191,206,230,268,340,342,361,421,606],"patients":[16,46,56,66,84,153,186,225,265,323,356,398,431,436,451,470,486,497,566,591,613,618,629,660],"with":[17,132,154,188,226,241,271,359,387,490,554,567,579,619,630,708],"multiple":[18],"myeloma":[19],"(MM)":[20],"when":[21],"using":[22],"the":[23,68,78,91,94,98,106,113,126,136,150,161,169,172,196,210,233,256,269,275,280,315,343,467,517,662],"novel":[24,71,164,473,533,677],"agents":[25,72,678],"thalidomide,":[26],"lenalidomide":[27],"bortezomib.":[29],"However,":[30],"outcome":[31,222],"data":[32,215],"provided":[33],"by":[34,90,112,203,326,462],"population-based":[35,143,208,650],"registries,":[36],"reflecting":[37],"real-life,":[38],"report":[39],"predominantly":[40],"OS":[42,52,151,483,492,519,536,564,589,608,667],"younger":[44],"MM":[45,55,65,138,155,229,360,469,659],"only":[48,479],"minimal":[49],"improvement":[50],"unselected":[54,64,658],"older":[57],"than":[58,565,590],"65":[59,330,401,403,510],"years.":[60],"Population-based":[61],"studies":[62],"era":[69,162],"of":[70,163,171,195,223,235,319,354,397,425,430,443,450,456,484,498,558,652,657,668,676],"are":[73,198],"relatively":[74],"limited.":[75],"Explanations":[76],"for":[77,493,612,628],"marked":[79],"variation":[80],"prognosis":[82,134],"across":[83],"may":[85,129],"part":[87],"be":[88,130],"explained":[89],"heterogeneity":[92],"initial":[95,178,703],"clinical":[96,217],"presentation,":[97],"pre-existing":[99],"comorbidities,":[100,219],"disease":[101],"biology":[102],"to":[105,148,167,238,279,337,538,617],"therapy.":[107],"Specific":[108],"end-organ":[109],"damage":[110],"caused":[111],"disease,":[114],"such":[115,695],"as":[116,125,696],"hypercalcemia,":[117],"renal":[118,700],"failure,":[119],"anemia":[120],"bone":[122,320],"lesions":[123],"known":[124],"CRAB":[127,173,285,441,454,583,594,693],"symptoms":[128,174,584,595],"associated":[131],"worse":[133,709],"elderly":[137],"patients.":[139,277],"This":[140],"descriptive":[141],"prospective":[142],"cohort":[144,656],"study":[145,270,651],"was":[146,253,287,367,378,417,671],"designed":[147],"determine":[149],"Friesland,":[157,192],"The":[158,322,363,412,481],"Netherlands":[159],"agents,":[165,474],"analyze":[168],"influence":[170],"comorbidities":[176],"at":[177,702],"presentation":[179,704],"on":[180,216,274],"survival.":[181],"Methods":[182],"Since":[183],"2005":[184,237,349],"all":[185,224,485,530],"diagnosed":[187,228,358],"hematological":[189],"malignancies":[190],"a":[193,207,242,352,388,453,555,561,568,586,631,653,665],"province":[194],"Netherlands,":[197],"prospectively":[199],"registered":[200],"followed":[202],"their":[204,463],"clinicians":[205],"registry,":[209],"HemoBase.":[211,250],"For":[212,529],"this":[213,649],"analysis,":[214,604],"characteristics,":[218],"treatment":[220],"newly":[227],"Friesland":[231],"during":[232],"period":[234,366],"January":[236,239,245],"2013":[240,351],"follow-up":[243],"until":[244],"2014":[246],"were":[247,266,324,357,399,432,459,609,705],"retrieved":[248],"from":[249,255,282],"Supplementary":[251],"information":[252],"obtained":[254],"individual":[257],"patient":[258],"hospital":[259],"records.":[260],"Both":[261],"symptomatic":[262,276,435,461,468,494],"asymptomatic":[264,496],"included":[267],"subgroup":[272],"analysis":[273],"According":[278],"guidelines":[281],"IMWG,":[283],"each":[284],"symptom":[286],"divided":[288,325],"into":[289,505],"two":[290,580],"categories":[291,507],"(11":[292],"mg/dL":[293,636,640],"<":[294,302,311,400,508,645],"serum":[295,632],"calcium":[296],"\u2264":[297,304,309,634],"11":[298],"mg/dL;":[299,306],"2":[300,305,571,635,639],"mg":[301],"creatinine":[303,633],"10.2":[307,312],"g/d":[308],"hemoglobin":[310],"g/dL":[313],"presence":[316],"or":[317,419,581],"absence":[318],"lesions).":[321],"age":[327,345,377,506,680],"groups":[328],"(<65,":[329],"\u2013":[331,511],"75":[332,405,409,512],"\u226575":[334,514],"years":[335,380,406,515],"old)":[336],"illustrate":[338],"differences":[339,605],"three":[344],"categories.":[346],"Results":[347],"From":[348],"till":[350],"total":[353],"270":[355],"Friesland.":[362],"median":[364,482,491,563,588,607,666,710],"observation":[365],"29":[368,525],"months":[369,502,526,670],"(range":[370,381],"0.26":[371],"-":[372,383,404],"104;":[373],"IQR":[374,385],"33).":[375],"Median":[376],"70":[379],"32":[382],"92;":[384],"15)":[386],"male":[389],"predominance":[390],"(60%":[391],"male).":[392],"34,":[393],"34":[394],"32%":[396],"years,":[402,410],"\u2265":[408,570,638,690],"respectively.":[411,427,447,503],"Charlson":[413],"Comorbidity":[414],"Index":[415],"(CCI)":[416],"0,1":[418],"\u22652":[420],"60,":[422],"22,":[423],"18%":[424],"patients,":[426,531],"Sixteen":[428],"percent":[429,449],"asymptomatic.":[433],"Of":[434],"63%":[437],"27%":[439],"had":[440,452],"scores":[442,688],"1-2":[444],"3-4,":[446],"Ten":[448],"score":[455,557,569],"0,":[457],"but":[458],"regarded":[460],"treating":[464],"hematologist.":[465],"Among":[466],"80%":[471],"received":[472],"15%":[475],"other":[476,539],"chemotherapy":[477],"6%":[478],"radiotherapy.":[480],"is":[487,520],"49.5":[488,669],"months,":[489,544],"40":[499,523],">100":[501],"Divided":[504],"65,":[509],"old,":[516],"50%":[518],"respectively":[521],"92,":[522],"(figure":[527],"1).":[528],"implementing":[532],"therapies":[534,540],"compared":[537,616],"(43.5":[541],"vs.":[542,637],"21.1":[543],"hazard":[545],"ratio":[546],"(HR)":[547],"=":[548,551,573,576,597,600,622,625,642],"1.8,":[549],"P":[550,575,599,624,644],"0.017.":[552],"Patients":[553,578],"CCI":[556],"0":[559],"higher":[562],"(HR":[572],"0.6,":[574,623],"0.036).":[577],"more":[582],"lower":[587],"without":[592,614],"any":[593],"(HRadjusted":[596],"2.2,":[598],"0.028).":[601],"In":[602,648],"multivariate":[603],"significant":[610],"better":[611],"hypercalcemia":[615,620,697],"(HRadj.":[621,641],"0.011)":[626],"0.4,":[643],"0.0001).":[646],"Conclusion":[647],"complete":[654],"Dutch":[655],"over":[661],"last":[663],"decade":[664],"observed.":[672],"Despite":[673],"extensive":[674],"introduction":[675],"increasing":[679],"remains":[681],"an":[682],"adverse":[683],"prognostic":[684],"factor.":[685],"High":[686],"comorbidity":[687],"(CCI":[689],"2)":[691],"symptoms,":[694],"impaired":[699],"function":[701],"significantly":[706],"correlated":[707],"OS.":[711],"Disclosures":[712],"Hovenga:":[713],"Jansen":[714],"Cilag:":[715,719,723],"Research":[716,720,724],"Funding.":[717,721,725],"Woolthuis:Jansen":[718],"Hoogendoorn:Jansen":[722]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-02-03T00:00:00"}